Company files IND with U.S. FDA for T-cell clinical trials.
Publication: Hematology Week
Publication Date: 27-DEC-04
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
2004 DEC 27 - (NewsRx.com & NewsRx.net) -- Stem-cell biotechnology and immunotherapy company CyGenics, Ltd., (CYN) announced that it had filed an investigational new drug application (IND) with the U.S. Food & Drug Administration (FDA).
This IND filing is for its phase I/II clinical trials, using T cells produced in its...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
